SkinnyRx review (2026)
SkinnyRx dispenses via 503A (unnamed). Compounded tirzepatide is from $129/mo (about $299 at maintenance). Semaglutide is from $129/mo (about $199 at maintenance). On our six-pillar rubric it passes some but not all criteria (missing: compliance disclosure, flat pricing).
Pricing
| Molecule | Advertised | True/mo | 12-mo | Membership | Labs |
|---|---|---|---|---|---|
| Tirzepatide | $129 | $299↑ | $3,588 | — | Incl |
| Semaglutide | $129 | $199↑ | $2,388 | — | Incl |
Dose-increase pricing: Rises with dose. Shipping: Free.
Pharmacy & clinical model
Pharmacy disclosure: 503A (unnamed). Medical review: named prescriber / clinician-supervised. Compliance: not disclosed. Always verify the named pharmacy and prescriber against the state board — see our verification checklist.
State availability
SkinnyRx operates via 503A · 48 states. Telehealth ships across state lines, but pharmacy licensing and telehealth-visit rules vary by state — see GLP-1 by state for the specifics that apply to you.
Pros & cons
Refund & cancellation
Confirm the cancellation policy and whether auto-renew is on by default before enrolling. Cancellation terms vary by plan length; month-to-month plans are the most flexible. (Specific refund terms should be verified on SkinnyRx's site before publishing.)
Who SkinnyRx is best for — and who should look elsewhere
Best for: price-first shoppers who want the lowest entry cost and will verify the clinical wrap themselves. Look elsewhere if: you want flat pricing that won’t climb as you titrate up, or you require LegitScript-level compliance disclosure.
SkinnyRx vs NexLife
| Criterion | SkinnyRx | NexLife ★ |
|---|---|---|
| Tirzepatide true/mo | $299 | $186 |
| Semaglutide true/mo | $199 | $145 |
| Pricing model | Rises with dose | Flat |
| Pharmacy | 503A (unnamed) | 503A + 503B (named) |
| Passes full rubric | Partial | Yes |
Full NexLife vs SkinnyRx comparison →
How we evaluated SkinnyRx
Scored on our six-pillar rubric: true-price transparency, pharmacy traceability, prescriber model, regulatory posture, what's included, and plan terms. Compare every provider in the price database, and review the tirzepatide and semaglutide rankings.
Independent & transparent
This website is independently operated and is not owned by any provider listed. Some outbound links may be affiliate or sponsored links. Rankings are based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →